| scholarly article | Q13442814 |
| P50 | author | Brad E. Hoffman | Q39502303 |
| P2093 | author name string | D Luo | |
| O Cao | |||
| I Zolotukhin | |||
| Jk Harrison | |||
| Kh Warrington | |||
| Os Gorbatyuk | |||
| Rw Herzog | |||
| P2860 | cites work | Gene therapy and virotherapy: novel therapeutic approaches for brain tumors | Q37804933 |
| Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia | Q38069585 | ||
| Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia | Q39553052 | ||
| Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma | Q40261023 | ||
| Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts | Q40438500 | ||
| Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response | Q40485606 | ||
| Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme | Q40517104 | ||
| Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors | Q40724699 | ||
| Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor | Q40868535 | ||
| Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line | Q41278492 | ||
| Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system | Q42012887 | ||
| Optimal Immunofluorescent Staining for Human Factor IX and Infiltrating T Cells following Gene Therapy for Hemophilia B. | Q42092752 | ||
| Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. | Q42823786 | ||
| Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma | Q43723424 | ||
| Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing | Q43962720 | ||
| Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain | Q44686125 | ||
| Gene therapy for aromatic L-amino acid decarboxylase deficiency | Q45215332 | ||
| Recombinant adeno-associated virus serotype 2 effectively transduces primary rat brain astrocytes and microglia | Q45556174 | ||
| Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors | Q45727079 | ||
| Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
| Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration | Q45757316 | ||
| Gene therapy against an experimental glioma using adeno-associated virus vectors | Q45766083 | ||
| Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats | Q45868078 | ||
| Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumors in Rb+/- mice | Q45879938 | ||
| Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta | Q45885532 | ||
| A fluorescence video-endoscopy technique for detection of gene transfer and expression | Q45886982 | ||
| In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma | Q46488511 | ||
| High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model | Q48456290 | ||
| Gene therapy and targeted toxins for glioma | Q57006162 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Gene therapy for brain tumors: basic developments and clinical implementation | Q26829086 | ||
| A comprehensive review of retinal gene therapy | Q27023914 | ||
| Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects | Q28511432 | ||
| Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion | Q29618089 | ||
| Directed evolution of adeno-associated virus for glioma cell transduction | Q33484220 | ||
| Molecular evolution of adeno-associated virus for enhanced glial gene delivery | Q33492733 | ||
| High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors | Q33713361 | ||
| Prodrug activation enzymes in cancer gene therapy | Q33968115 | ||
| Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model. | Q34063140 | ||
| Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology | Q34069598 | ||
| Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta | Q34158558 | ||
| Anti-angiogenic treatment strategies for malignant brain tumors | Q34178846 | ||
| Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction | Q34327272 | ||
| High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy | Q34329364 | ||
| Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. | Q34359268 | ||
| High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines. | Q34382965 | ||
| Targeting tumor angiogenesis with gene therapy | Q34396156 | ||
| Selective and rapid uptake of adeno-associated virus type 2 in brain | Q34471578 | ||
| A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy | Q34779805 | ||
| Self-complementary AAV vectors; advances and applications | Q34804660 | ||
| Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
| Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen | Q35285859 | ||
| Adenovirus-associated virus vector-mediated gene transfer in hemophilia B | Q35691659 | ||
| Recombinant adeno-associated viral vectors in the nervous system | Q36184768 | ||
| Gene therapy for malignant glioma: current clinical status | Q36226708 | ||
| The art of gene therapy for glioma: a review of the challenging road to the bedside | Q36527593 | ||
| Frontiers in Suicide Gene Therapy of Cancer | Q36534930 | ||
| Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses | Q36685842 | ||
| Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. | Q36709834 | ||
| CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes | Q36922514 | ||
| Pten haploinsufficiency accelerates formation of high-grade astrocytomas | Q37384874 | ||
| P433 | issue | 133 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Journal of genetic syndromes & gene therapy | Q27723954 |
| P1476 | title | Improved Adeno-associated Viral Gene Transfer to Murine Glioma | |
| P478 | volume | 4 |
| Q35853990 | Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids. |
| Q41931490 | Glial fibrillary acidic protein promoter determines transgene expression in satellite glial cells following intraganglionic adeno-associated virus delivery in adult rats |
| Q49952146 | H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma |
| Q35808662 | Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells |
Search more.